Zebrafish as a Potential Model for Neurodegenerative Diseases: A Focus on Toxic Metals Implications

被引:20
|
作者
Paduraru, Emanuela [1 ]
Iacob, Diana [1 ]
Rarinca, Viorica [1 ,2 ]
Plavan, Gabriel [2 ]
Ureche, Dorel [3 ]
Jijie, Roxana [4 ]
Nicoara, Mircea [1 ,2 ]
机构
[1] Alexandru Ioan Cuza Univ, Fac Geog & Geol, Doctoral Sch Geosci, 20A Carol I Ave, Iasi 700505, Romania
[2] Alexandru Ioan Cuza Univ, Fac Biol, Dept Biol, 20A Carol I Ave, Iasi 700505, Romania
[3] Vasile Alecsandri Univ Bacau, Fac Sci, Dept Biol Ecol & Environm Protect, 157 Marasesti St, Bacau 600115, Romania
[4] Alexandru Ioan Cuza Univ, Inst Interdisciplinary Res, Res Ctr Adv Mat & Technol, Dept Exact & Nat Sci, 11 Carol I Ave, Iasi 700506, Romania
关键词
neurotoxicity; heavy metals; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; zebrafish; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HEAVY-METALS; DANIO-RERIO; LEAD PB; INORGANIC MERCURY; METHYLMERCURY EXPOSURE; DIETARY METHYLMERCURY; SWIMMING PERFORMANCE; EMBRYONIC EXPOSURE;
D O I
10.3390/ijms24043428
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the last century, industrial activities increased and caused multiple health problems for humans and animals. At this moment, heavy metals are considered the most harmful substances for their effects on organisms and humans. The impact of these toxic metals, which have no biological role, poses a considerable threat and is associated with several health problems. Heavy metals can interfere with metabolic processes and can sometimes act as pseudo-elements. The zebrafish is an animal model progressively used to expose the toxic effects of diverse compounds and to find treatments for different devastating diseases that human beings are currently facing. This review aims to analyse and discuss the value of zebrafish as animal models used in neurological conditions, such as Alzheimer's disease (AD), and Parkinson's disease (PD), particularly in terms of the benefits of animal models and the limitations that exist.
引用
收藏
页数:35
相关论文
共 50 条
  • [1] Mitohormesis; Potential implications in neurodegenerative diseases
    Gohel, Dhruv
    Singh, Rajesh
    MITOCHONDRION, 2021, 56 : 40 - 46
  • [2] Potential implications of polyphenolic compounds in neurodegenerative diseases
    Shi, Ruidie
    Gao, Daili
    Stoika, Rostyslav
    Liu, Kechun
    Sik, Attila
    Jin, Meng
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2022, 64 (16) : 5491 - 5514
  • [3] Transgenic zebrafish models of neurodegenerative diseases
    Jonathan J. Sager
    Qing Bai
    Edward A. Burton
    Brain Structure and Function, 2010, 214 : 285 - 302
  • [4] Genetic zebrafish models of neurodegenerative diseases
    Bandmann, Oliver
    Burton, Edward A.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 58 - 65
  • [5] Transgenic zebrafish models of neurodegenerative diseases
    Sager, Jonathan J.
    Bai, Qing
    Burton, Edward A.
    BRAIN STRUCTURE & FUNCTION, 2010, 214 (2-3): : 285 - 302
  • [6] Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs
    D. Caccamo
    L. R. Pisani
    P. Mazzocchetti
    R. Ientile
    P. Calabresi
    F. Pisani
    C. Costa
    Neurochemical Research, 2016, 41 : 340 - 352
  • [7] Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs
    Caccamo, D.
    Pisani, L. R.
    Mazzocchetti, P.
    Ientile, R.
    Calabresi, P.
    Pisani, F.
    Costa, C.
    NEUROCHEMICAL RESEARCH, 2016, 41 (1-2) : 340 - 352
  • [8] The role of metals in neurodegenerative diseases
    Sayre, LM
    Perry, G
    Atwood, CS
    Smith, MA
    CELLULAR AND MOLECULAR BIOLOGY, 2000, 46 (04) : 731 - 741
  • [9] Resveratrol: A Focus on Several Neurodegenerative Diseases
    Tellone, Ester
    Galtieri, Antonio
    Russo, Annamaria
    Giardina, Bruno
    Ficarra, Silvana
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015, 2015
  • [10] Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
    Valera, Elvira
    Masliah, Eliezer
    PHARMACOLOGY & THERAPEUTICS, 2013, 138 (03) : 311 - 322